Location History:
- Fairlawn, OH (US) (2008)
- Clinton Township, MI (US) (2015 - 2022)
- Monroe, NY (US) (2016 - 2024)
Company Filing History:
12 out of 4,455 
6 out of 832,761 Years Active: 2008-2025
Title: The Innovations of David Cooper: Pioneering Immunogenic Compositions for Pneumococcal Vaccines
Introduction
David Cooper, an accomplished inventor based in Monroe, NY, has made significant contributions to the field of immunology with a portfolio of 18 patents. His innovative work primarily focuses on developing new immunogenic compositions aimed at enhancing the efficacy of pneumococcal vaccines, thereby improving public health outcomes.
Latest Patents
David's latest patents include groundbreaking inventions such as "Immunogenic compositions for use in pneumococcal vaccines." This invention aims to provide immunogenic compositions that specifically protect against serogroup 18 while minimizing the number of conjugates used. It addresses the urgent need for effective vaccination strategies in human subjects, especially among vulnerable populations like infants and the elderly.
Another notable patent is "Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof." This patent details new compositions that include glycoconjugates from serotypes not found in prominent vaccines like PREVNAR®, SYNFLORIX®, and PREVNAR 13®. This innovation seeks to enhance the vaccination possibilities against pneumococcal infections.
Career Highlights
In his career, David Cooper has worked with renowned organizations, including Pfizer Corporation, where he contributed to cutting-edge research and development. His role at Pfizer has allowed him to collaborate on projects that have a lasting impact on public health, particularly in the vaccine sphere.
Collaborations
Throughout his illustrious career, David has had the opportunity to work alongside notable professionals, including Kathrin Ute Jansen and Michael William Pride. These collaborations have significantly enriched his research and development efforts, fostering innovations that could shape the future of vaccines.
Conclusion
David Cooper stands as a remarkable figure in the realm of inventions related to immunogenic compositions, especially in the field of pneumococcal vaccines. His 18 patents speak volumes about his dedication to advancing healthcare solutions and improving the lives of countless individuals. As he continues his work, the impact of his innovations is likely to be profound and enduring.